We have further examined this initial finding using quantitative PCR (qPCR) analysis, western immunoblotting of the same cell lines, chemosensitivity testing and analysis of freshly extracted ovarian cancer tissue for mRNA levels of p57Kip2 with assessment of clinico-pathological features. This evidence concerns the gene CDKN1C and ovarian carcinoma.